Cat. No. | Product Name | Target | Signaling Pathways |
---|---|---|---|
T27627 |
Iroxanadine
BRX005,BRX-235,BRX-005,BRX235,BRX 005,BRX 235 |
p38 MAPK | MAPK |
Iroxanadine (BRX-005) 是一种新型小分子MAPK p38 抑制剂,诱导p38 SAPK 的磷酸化,在用去氧肾上腺素预先收缩的豚鼠肺动脉制剂中诱导浓度依赖性松弛,可用于治疗动脉粥样硬化、糖尿病血管病,微血管心绞痛和外周动脉疾病等血管疾病。 | |||
T69521 |
Iroxanadine hydrochloride
|
||
Iroxanadine hydrochloride is a MAPK p38 inhibitor potentially for the treatment of atherosclerosis. | |||
T69519 |
Iroxanadine hydrobromide
|
||
Iroxanadine hydrobromide is a MAPK p38 inhibitor potentially for the treatment of atherosclerosis. | |||
T69520 |
Iroxanadine sulfate
|
||
Iroxanadine sulfate is a MAPK p38 inhibitor potentially for the treatment of atherosclerosis. |